HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Studies on the prevention of nigericin action in neuroblastoma X glioma hybrid (NG108-15) cells.

Abstract
Electrophysiological analysis of neuroblastoma X glioma hybrid (NG108-15) cells was used as an in vitro neuronal model system to evaluate antagonists of the K+-selective carboxylic ionophore, nigericin. Changes in membrane electrical characteristics induced by nigericin with and without the simultaneous administration of antagonists were measured using intracellular microelectrode techniques. Bath application of nigericin (3 microM) produced a severe hyperpolarization and blocked the generation of action potentials in response to electrical stimulation. Simultaneous administration of nigericin plus the Na+-K+ pump inhibitor ouabain or drugs known to influence Ca++ signaling in cells, i.e., quinidine, compound R24571, verapamil or haloperidol, was able to significantly attenuate the hyperpolarization. All antagonists acted in a concentration-dependent manner. However, nigericin plus maximally effective concentrations of ouabain (1 microM), verapamil (3 microM) and haloperidol (3 and 10 microM) resulted in moderate-to-severe depolarization by the end of 24 min. superfusions, suggesting that the concentrations of antagonists were excessive and that NG108-15 cell damage had occurred. In addition, none of the compounds studied was able to effectively prevent nigericin-induced blockade of action potentials. Thus, none of these antagonists appears suitable for transition to in vivo antidotal protection studies.
AuthorsJ A Doebler
JournalPharmacology & toxicology (Pharmacol Toxicol) Vol. 87 Issue 2 Pg. 63-8 (Aug 2000) ISSN: 0901-9928 [Print] Denmark
PMID10989942 (Publication Type: Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Enzyme Inhibitors
  • Ionophores
  • Ouabain
  • Verapamil
  • Quinidine
  • Nigericin
Topics
  • Calcium Channel Blockers (pharmacology)
  • Electrophysiology
  • Enzyme Inhibitors (pharmacology)
  • Ionophores (antagonists & inhibitors, pharmacology)
  • Membrane Potentials (drug effects)
  • Neuroblastoma (metabolism)
  • Nigericin (antagonists & inhibitors, pharmacology)
  • Ouabain (pharmacology)
  • Quinidine (pharmacology)
  • Tumor Cells, Cultured (drug effects)
  • Verapamil (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: